Psychiatry & Neurology, Clinical Neurophysiology · New Orleans, LA
NPI
1699978122
Since 2007
Specialty
Psychiatry & Neurology, Clinical Neurophysiology
Code 2084N0600X
Group practices
1
Medicare group memberships
Hospitals
5
Hospital affiliations
1514 Jefferson Hwy
New Orleans, LA, 70121
Phone (504) 842-4000
Groups this clinician bills Medicare through
Medicare paid, 2024
$30K
308 services
Medicare patients, 2024
169
Average age 68
Drug cost, 2024
$958K
2,058 prescriptions
Company payments, 2025
$92K
From 12 companies
Procedures and visits billed to Original Medicare, 2024
In 2024, the most common Medicare service billed by Fawad A Khan was code 95720 (neurologic), 102 times for 52 patients. In total Fawad A Khan billed 308 services in 21 codes, and Medicare paid $30K.
| Code |
|---|
Official US government data: the national provider registry and Medicare enrollment records, linked by NPI. Last update of this record: 2013-01-15.
| Setting |
|---|
| Services |
|---|
| Patients |
|---|
| Paid per service |
|---|
| Medicare paid |
|---|
| 95720 Neurologic | Facility | 102 | 52 | $155.31 | $16K |
| 64615 Musculoskeletal | Facility | 31 | 13 | $85.93 | $2,664 |
| 99214 Office E&M - Established | Facility | 26 | 23 | $64.06 | $1,666 |
| 95816 Neurologic | Facility | 24 | 24 | $39.27 | $942 |
| 95819 Neurologic | Facility | 24 | 24 | $38.90 | $934 |
| 95718 Neurologic | Facility | 19 | 16 | $102.15 | $1,941 |
By year: 2022 $42K for 394 services; 2023 $29K for 286 services; 2024 $30K for 308 services.
Medicare prescription drug claims, 2024
In 2024, the drug Fawad A Khan prescribed most often to Medicare patients was Lacosamide, with 217 prescriptions and refills. In total Fawad A Khan wrote 2,058 Medicare prescriptions that cost $958K.
| Drug | Claims | 30-day fills | Patients | Cost |
|---|---|---|---|---|
| Lacosamide Generic | 217 | 258 | 25 | $18K |
| Clobazam Generic | 102 | 106 | 17 | $23K |
| Aimovig Autoinjector Erenumab-Aooe | 85 | 98 | 14 | $73K |
| Emgality Pen Galcanezumab-Gnlm | 81 | 81 | 13 | $59K |
| Lamotrigine Generic | 79 | 199 | 21 | $1,890 |
| Topiramate Generic | 78 | 207 | 20 | $1,161 |
| Levetiracetam Generic | 75 | 137 | 15 | $2,526 |
| Zonisamide Generic | 72 | 126 | 15 | $2,576 |
| Gabapentin Generic | 66 | 88 | 15 | $760 |
| Sumatriptan Succinate Generic | 60 | 70 | 13 | $2,434 |
| Rizatriptan Rizatriptan Benzoate | 57 | 59 | Under 11 | $720 |
| Butalbital-Acetaminophen-Caffe Butalb/Acetaminophen/Caffeine | 51 | 53 | Under 11 | $590 |
| Briviact Brivaracetam | 50 | 50 | Under 11 | $88K |
| Ubrelvy Ubrogepant | 50 | 50 | Under 11 | $41K |
| Aptiom Eslicarbazepine Acetate | 34 | 34 | Under 11 | $92K |
Brand drugs: 517 claims; generic drugs: 1,507 claims.
Money and other things of value reported by the companies
In 2025, drug and medical device companies paid Fawad A Khan $92K ($92K in general payments such as food, travel and fees) from 12 companies. The largest payer was Pfizer Inc. with $37K.
Official US government data on Original Medicare services, Medicare prescription drug plans and the payments drug and device companies must report. Services with fewer than 11 patients and drugs with fewer than 11 claims are not published. Procedure codes are shown by number with their public category.